Nobody knows, at least for now, how the “end game” for potential tariffs by the US will play out and companies like Dr Reddy’s Laboratories (DRL) are preparing for “all options” and to primarily secure the supply of products.
Key Takeaways
- Dr Reddy’s preps for “all options” to secure US supplies amid spectre of tariffs.
At the earnings call for the fourth quarter of fiscal 2025, DRL’s CEO Erez Israeli said that the company’s main...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?